Location History:
- Samobor, HR (2011)
- Zagreb, HR (2007 - 2012)
Company Filing History:
4 out of 1,168 
1 out of 1 
1 out of 5 Years Active: 2007-2012
Title: Unveiling the Innovations of Inventor Zorica Marusic-Istuk
Introduction: Zorica Marusic-Istuk, a distinguished inventor based in Zagreb, HR, has made significant contributions to the field of pharmaceuticals with a total of 4 patents to his name. His groundbreaking work spans the development of anti-inflammatory macrolides and novel semi-synthetic macrolides with anti-inflammatory properties.
Latest Patents:
1. Anti-inflammatory macrolide: Marusic-Istuk's patented compound 3'-N-demethyl-4''-O-(2-diethylaminoethanoyl)-6-O-methyl-9a-aza-9a-homoerythromycin A shows great promise in the treatment of neutrophil-dominated inflammatory diseases. This patent encompasses the compound, its pharmaceutical compositions, and methods for its preparation.
2. Macrolides with anti-inflammatory activity: The inventor's work extends to novel semi-synthetic macrolides with anti-inflammatory properties, particularly focusing on 14- and 15-membered macrolides substituted at the 4'' position. These compounds offer potential in treating inflammatory diseases associated with excessive secretion of various cytokines and lymphocyte proliferation inhibitors.
Career Highlights: Marusic-Istuk's journey includes notable stints at Glaxo Group Limited and GlaxoSmithKline Istrazivacki Centar Zagreb D.o.o. His expertise and dedication have been instrumental in advancing pharmaceutical research and development in these renowned organizations.
Collaborations: Throughout his career, Zorica Marusic-Istuk has collaborated with esteemed professionals in the field, including coworkers Antun Hutinec and Goran Kragol. These collaborations have fostered innovation and shared knowledge, leading to impactful discoveries in the realm of pharmaceuticals.
Conclusion: Zorica Marusic-Istuk stands as a visionary inventor whose work has significantly contributed to the advancement of anti-inflammatory therapies. His patents and collaborations reflect a deep commitment to improving healthcare outcomes and addressing unmet medical needs.